Philosophy of Care

My approach to care is rooted in compassion and trust. I believe that when we seek medical care, we deserve to feel safe, heard, and respected. It is a privilege to be entrusted with your care, and we take that responsibility seriously. My goal is to honor the promise we make as healthcare professionals: to provide you with the highest quality care, guided by integrity, empathy, and expertise.

Clinical Interests

Dr. Jayasundera came to UC Davis Health from the University of Michigan, Ann Arbor. There he served as the Paul R. Lichter Professor of Ophthalmic Genetics and professor of ophthalmology and visual sciences at the university’s Kellogg Eye Center. Dr. Jayasundera is a retina specialist specializing in Inherited Retinal Diseases such as retinitis pigmentosa, Stargardt disease, rod-cone dystrophy, cone dystrophy, achromatopsia, Leber congenital amaurosis, X-linked retinoschisis, Best disease, and choroideremia.

He also sees patients with retinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, central serous chorioretinopathy, retinal artery occlusion, hypertensive retinopathy, radiation retinopathy, sickle cell retinopathy,coats disease, macular edema, pattern dystrophy, macular telangiectasia, toxic retinopathies, autoimmune retinopathy, and cancer-associated retinopathy. 

He utilizes retinal electrophysiological testing to understand the retinal function in conditions that may be ambiguous to conventional examination and imaging modalities. 

Research/Academic Interests

Dr. Jayasundera specializes in retinal diseases and is known internationally for inherited retinal diseases. He built his distinguished career by focusing on improving treatments and providing mental health support for patients with inherited retinal diseases. A passionate researcher and innovator, Dr. Jayasundera has led numerous groundbreaking studies funded by the National Institutes of Health, Foundation Fighting Blindness and other major organizations. He developed the Michigan Retinal Degeneration Questionnaire and the Michigan Vision-related Anxiety Questionnaire, which transformed how patient-reported outcomes are measured in clinical trials for inherited retinal diseases. He is the Principal Investigator of a NIH R01 funded clinical trial assessing the optimization of Low Vision Rehabilitation when combined with Emotion Regulation Therapy to improve functional vision limitations and vision-related anxiety. 

Division

Ophthalmology